ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 10 mg - donepezil

ישראל - עברית - Ministry of Health

unipharm ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 10 mg

ישראל - עברית - Ministry of Health

unipharm ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 5 mg

ישראל - עברית - Ministry of Health

dexcel ltd, israel - rivastigmine as hydrogen tartrate - קפסולה קשיחה - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine

ישראל - עברית - Ministry of Health

dexcel ltd, israel - rivastigmine as hydrogen tartrate - קפסולה קשיחה - rivastigmine as hydrogen tartrate 3 mg - rivastigmine

ישראל - עברית - Ministry of Health

dexcel ltd, israel - rivastigmine as hydrogen tartrate - קפסולה קשיחה - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine

ישראל - עברית - Ministry of Health

dexcel ltd, israel - rivastigmine as hydrogen tartrate - קפסולה קשיחה - rivastigmine as hydrogen tartrate 6 mg - rivastigmine

ישראל - עברית - Ministry of Health

dexcel ltd, israel - rivastigmine - מדבקות - rivastigmine 6.9 mg - rivastigmine

ישראל - עברית - Ministry of Health

dexcel ltd, israel - rivastigmine - מדבקות - rivastigmine 13.8 mg - rivastigmine

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.